(Q38143182)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Cancer vaccination by electro-gene-transfer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Luigi Aurisicchio

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Rita Mancini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

25 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

1127-1137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

Sipuleucel-T for the treatment of advanced prostate cancer

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Cancer immunotherapy comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Cancer vaccines: should we be targeting patients with less aggressive disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Genetic cancer vaccines: current status and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Desirable cell death during anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Chemoimmunotherapy: reengineering tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Natural innate and adaptive immunity to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

DNA vaccines: an historical perspective and view to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Human clinical trials of plasmid DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Electroporation delivery of DNA vaccines: prospects for success

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

DNA electrotransfer: its principles and an updated review of its therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

What you always needed to know about electroporation based DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Fundamentals of electroporative delivery of drugs and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Gene transfer by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Electro-gene-transfer: a new approach for muscle gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Transient and stable ionic permeabilization of isolated skeletal muscle cells after electrical shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Gene electro-transfer improves transduction by modifying the fate of intramuscular DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Electroporation advances in large animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

DNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

A novel electroporation device for gene delivery in large animals and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Enhancing immune responses using suicidal DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Nonviral delivery of self-amplifying RNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Intradermal electroporation of naked replicon RNA elicits strong immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Heterologous prime-boost vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

ErbB2 genetic cancer vaccine in nonhuman primates: relevance of single nucleotide polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

DNA and Adenoviral Vectors Encoding Carcinoembryonic Antigen Fused to Immunoenhancing Sequences Augment Antigen-Specific Immune Response and Confer Tumor Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

Gene Electrotransfer Results in a High-Level Transduction of Rat Skeletal Muscle and Corrects Anemia of Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836903

10.1586/14760584.2013.836903

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24066796%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference